Anna E. Vilgelm
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 28
- Cancer-related Molecular Pathways 12
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 5
- CAR-T cell therapy research 4
- Chemokine receptors and signaling 4
- Immunology 14
- Immunotherapy and Immune Responses 10
- Co-authors
- Ann J. Richmond (24 shared papers)Alexander I. Zaika (8 shared papers)Dr. Amrendra Kumar (6 shared papers)Douglas Buckner Johnson (5 shared papers)Wael M. El-Rifai (4 shared papers)Sheau‐Chiann Chen (11 shared papers)Jinming Yang (7 shared papers)Mark Carlton Kelley (9 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Cell Reports (3 papers)Oncogene (3 papers)Gastroenterology (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesRussiaJapan
In The Last Decade
Anna E. Vilgelm
49 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 103
- Oncology 1.4k
- Immunology 881
- Cancer Research 233
- Biotechnology 131
- Molecular Biology 858
Countries citing papers authored by Anna E. Vilgelm
This map shows the geographic impact of Anna E. Vilgelm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Vilgelm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Vilgelm more than expected).
Fields of papers citing papers by Anna E. Vilgelm
This network shows the impact of papers produced by Anna E. Vilgelm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Vilgelm. The network helps show where Anna E. Vilgelm may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna E. Vilgelm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 468 | |
| 2 | 2019 | 304 | |
| 3 | 2010 | 168 | |
| 4 | 2021 | 107 | |
| 5 | 2016 | 98 | |
| 6 | 2019 | 98 | |
| 7 | 2016 | 92 | |
| 8 | 2014 | 89 | |
| 9 | 2012 | 87 | |
| 10 | 2006 | 86 | |
| 11 | 2015 | 81 | |
| 12 | 2021 | 71 | |
| 13 | 2020 | 68 | |
| 14 | 2020 | 62 | |
| 15 | 2018 | 62 | |
| 16 | 2019 | 58 | |
| 17 | 2008 | 55 | |
| 18 | 2013 | 54 | |
| 19 | 2012 | 53 | |
| 20 | 2008 | 48 |
About Anna E. Vilgelm
Anna E. Vilgelm is a scholar working on Oncology, Immunology, Biotechnology, Molecular Biology and Cancer Research, having authored 50 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Research and Treatments (6 papers), Cancer Cells and Metastasis (5 papers), CAR-T cell therapy research (4 papers), Chemokine receptors and signaling (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (881 citations), Cancer Research (233 citations), Biotechnology (131 citations) and Molecular Biology (858 citations). Anna E. Vilgelm has collaborated with scholars based in United States, Russia and Japan. Frequent co-authors include Ann J. Richmond, Alexander I. Zaika, Dr. Amrendra Kumar, Douglas Buckner Johnson, Wael M. El-Rifai, Sheau‐Chiann Chen, Jinming Yang, Mark Carlton Kelley, Gregory Dan Ayers and Jinxiong Wei. Their work appears in journals such as Clinical Cancer Research, Cell Reports, Oncogene, Gastroenterology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.